Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders.

Conti V, Lora A, Cipriani A, Fortino I, Merlino L, Barbui C.

Eur J Clin Pharmacol. 2012 Dec;68(12):1647-55. doi: 10.1007/s00228-012-1298-2. Epub 2012 May 10.

PMID:
22573134
2.

Adequacy of treatment for patients with schizophrenia spectrum disorders and affective disorders in Lombardy, Italy.

Lora A, Conti V, Leoni O, Rivolta AL.

Psychiatr Serv. 2011 Sep;62(9):1079-84. doi: 10.1176/appi.ps.62.9.1079.

PMID:
21885588
3.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
4.

The mental health system in Lombardy, Italy: access to services and patterns of care.

Lora A, Barbato A, Cerati G, Erlicher A, Percudani M.

Soc Psychiatry Psychiatr Epidemiol. 2012 Mar;47(3):447-54. doi: 10.1007/s00127-011-0352-1. Epub 2011 Feb 4.

PMID:
21293841
5.

Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.

Clark RE, Xie H, Brunette MF.

J Clin Psychiatry. 2004 Feb;65(2):151-5.

PMID:
15003066
6.

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness.

J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8. Review.

7.

One-year treatment continuation in patients prescribed risperidone long-acting injection in New Zealand: a retrospective study.

Wheeler A, Vanderpyl J, Carswell C, Stojkovic M, Robinson E.

Clin Schizophr Relat Psychoses. 2012 Jul;6(2):61-8. doi: 10.3371/CSRP.6.2.3.

PMID:
22776632
8.

[Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].

Norton J, de Roquefeuil G, David M, Boulenger JP, Ritchie K, Mann A.

Encephale. 2009 Dec;35(6):560-9. doi: 10.1016/j.encep.2008.06.018. Epub . French.

PMID:
20004287
9.
10.

Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses.

Stensland MD, Schultz JF, Frytak JR.

BMC Psychiatry. 2010 Jun 4;10:39. doi: 10.1186/1471-244X-10-39.

11.

[Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].

Dakhlaoui O, Essafi I, Haffani F.

Encephale. 2008 Sep;34(4):337-42. doi: 10.1016/j.encep.2007.06.008. Epub 2007 Oct 26. French.

PMID:
18922234
12.

A trial of problem-solving by community mental health nurses for anxiety, depression and life difficulties among general practice patients. The CPN-GP study.

Kendrick T, Simons L, Mynors-Wallis L, Gray A, Lathlean J, Pickering R, Harris S, Rivero-Arias O, Gerard K, Thompson C.

Health Technol Assess. 2005 Sep;9(37):1-104, iii.

13.

Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).

Barraco A, Rossi A, Nicolò G; EPHAR Study Group.

CNS Neurosci Ther. 2012 Feb;18(2):110-8. doi: 10.1111/j.1755-5949.2010.00225.x. Epub 2010 Dec 28.

PMID:
21199448
14.

[The population treated in the general psychiatric sector in 1993 and 1998. Clinical and demographic evolution].

Casadebaig F, Ruffin D, Quemada N.

Rev Epidemiol Sante Publique. 2001 Dec;49(6):513-21. French.

PMID:
11845100
15.

Prevalence and factors associated with medication compliance in Indian patients suffering from mental disorders.

Sharma S, Kumar N, Chakraborti S, Sinha S, Kumari S, Gajendragad JM.

Trop Doct. 2012 Jan;42(1):28-31. doi: 10.1258/td.2011.110009. Epub 2011 Oct 28.

PMID:
22037517
17.

Treatment for co-occurring mental and substance use disorders in five state Medicaid programs.

Clark RE, Samnaliev M, McGovern MP.

Psychiatr Serv. 2007 Jul;58(7):942-8.

PMID:
17602010
18.

Accessibility and pathways to psychiatric care in a community-based mental health system.

Amaddeo F, Zambello F, Tansella M, Thornicroft G.

Soc Psychiatry Psychiatr Epidemiol. 2001 Oct;36(10):500-7.

PMID:
11768848
20.

Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective.

Cui Z, Faries DE, Gelwicks S, Novick D, Liu X.

J Med Econ. 2012;15(1):134-44. doi: 10.3111/13696998.2011.632043. Epub 2011 Nov 2.

PMID:
22014076
Items per page

Supplemental Content

Write to the Help Desk